| Filed On | Filing |
|---|---|
| 23 Aug 2024 |
8-K/A: Departure/Election of Directors or Officers; Compensation
This letter sets forth the terms of your employment as Chief Executive Officer of Arcadia Biosciences, Inc. (the “Company”), a position you have held since July 5, 2024 (the “Effective Date”). The terms set forth below shall be effective... |
| 05 Jan 2023 |
8-K/A: Departure/Election of Directors or Officers; Compensation
This letter sets forth the terms of your employment as Chief Financial Officer of Arcadia Biosciences, Inc. (the “Company”), as of January 3, 2023 (the “Effective Date”). The terms set forth below shall be effective as of the Effective D... |
| 12 Oct 2021 | 8-K/A: Submission of Matters to a Vote of Security Holders |
| 02 Aug 2021 | 8-K/A: Financial Statements and Exhibits |
| 07 Oct 2019 | 8-K/A: Departure/Election of Directors or Officers; Compensation |
Loading...
